Weekly vs 3-weekly cisplatin: a retrospective cohort study

被引：0
|
作者：
Saerens, Michael [1 ,2 ]
Van den Broeck, Alexander [2 ]
de Weghe, Geertrui Van [2 ]
Wouter, Huvenne [3 ,4 ]
Peter, Tomassen [3 ,4 ]
Wouter, Bauters [5 ]
Vermassen, Tijl [1 ,2 ]
Sarah, Deschuymer [6 ,7 ]
Rottey, Sylvie [1 ,2 ,8 ]
Duprez, Frederic [6 ,7 ]
机构：
[1] Ghent Univ Hosp, Med Oncol, Ghent, Belgium
[2] Univ Ghent, Basic & Appl Med Sci, Ghent, Belgium
[3] Ghent Univ Hosp, Head & Neck Surg, Ghent, Belgium
[4] Univ Ghent, Head & Skin, Ghent, Belgium
[5] Ghent Univ Hosp, Radiol, Ghent, Belgium
[6] Ghent Univ Hosp, Radiotherapy, Ghent, Belgium
[7] Univ Ghent, Human Struct & Repair, Ghent, Belgium
[8] Ghent Univ Hosp, Drug Res Unit, Ghent, Belgium
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 192卷
关键词：
Chemoradiotherapy; cisplatin; toxicity;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
229
引用
收藏
页码：S280 / S283
页数：5
相关论文
共 50 条
  • [21] A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
    Tabernero, J
    Climent, MA
    Lluch, A
    Albanell, J
    Vermorken, JB
    Barnadas, A
    Antón, A
    Laurent, C
    Mayordomo, JI
    Estaun, N
    Losa, I
    Guillem, V
    Garcia-Conde, J
    Tisaire, JL
    Baselga, J
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1358 - 1365
  • [22] A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study
    Meng, Dong-Fang
    Sun, Rui
    Peng, Li-Xia
    Huang, You-Sheng
    Yang, Qin
    Luo, Dong-Hua
    Hu, Wei-Han
    Xie, Fang-Yun
    Luo, Wei
    Zhao, Chong
    Guo, Ling
    Mai, Hai-Qiang
    Chen, Ming-Yuan
    Xie, Ping
    Zheng, Li-Sheng
    Yang, Jun-Ping
    Mei, Yan
    Qiang, Yuan-Yuan
    Xu, Liang
    Li, Chang-Zhi
    Huang, Bi-Jun
    Qian, Chao-Nan
    Sun, Rui
    JOURNAL OF CANCER, 2018, 9 (01): : 92 - 99
  • [23] Comparison of 2-Weekly and 3-Weekly Dosing of Docetaxel in Metastatic Prostate Cancer
    Martinez-Recio, Sergio
    Perez-Wert, Juan Pablo
    Martinez-Fdez, Sara
    Jimenez-Bou, Diego
    Ruiz-Gutierrez, Iciar
    Pena, Jesus
    Pertejo, Ana
    Espinosa, Enrique
    Pinto, Alvaro
    CLINICAL GENITOURINARY CANCER, 2022, 20 (04) : 363 - 370
  • [24] Comparison of standard-dose 3-weekly cisplatin and low-dose weekly cisplatin for concurrent chemoradiation of patients with locally advanced head and neck squamous cell cancer: A multicenter retrospective analysis
    Lee, So Yeon
    Choi, Yoon Seok
    Song, Ik-Chan
    Park, Sang Gon
    Keam, Bhumsuk
    Yang, Young Jun
    Song, Eun-Kee
    Lee, Hyo Jin
    Cho, Sang-Hee
    Shim, Hyeok
    Park, Keon Uk
    Lee, Ki-Hyeong
    Jo, Deog-Yeon
    Jo, Ihn-Seong
    Yun, Hwan-Jung
    MEDICINE, 2018, 97 (21)
  • [25] Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer.
    Espeli, V.
    Zucca, E.
    Ghielmini, M. E. G.
    Richetti, A.
    Giannini, O.
    Martucci, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] COMPARISON OF ACUTE TOXICITY PROFILE OF WEEKLY VERSUS 3-WEEKLY CISPLATIN IN CONCURRENT CHEMORADIATION FOR LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Thommachan, K. Cessal
    Kumar, R. Ravi
    Haridas, G. Medini
    Sudha, A. Sankar
    Rafi, M.
    Ramadas, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S12 - S12
  • [27] THE COMPARATIVE EVALUATION OF RADIOTHERAPY WITH CONCURRENT WEEKLY CISPLATIN VERSUS CONCURRENT 3-WEEKLY CISPLATIN AND ETOPOSIDE IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED NON SMALL CELL LUNG CANCER
    Bagri, P. K.
    Hirapara, P.
    Kapoor, A.
    Singhal, M.
    Singh, D.
    Jakhar, S. L.
    Beniwal, S. K.
    Sharma, N.
    Kumar, H.
    Sharma, A.
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S35 - S36
  • [28] Dose intensity comparison between weekly and 3-weekly Cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: A retrospective comparison from New Cross Hospital, Wolverhampton, UK
    Ho, Kean F.
    Swindell, Ric
    Brammer, Caroline V.
    ACTA ONCOLOGICA, 2008, 47 (08) : 1513 - 1518
  • [29] Dose-dense chemotherapy with weekly paclitaxel and 3-weekly carboplatin for recurrent ovarian cancer
    Chen, Wei-Chun
    Huang, Huei-Jean
    Chang, Ting-Chang
    Chou, Hung-Hsueh
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2020, 59 (01): : 21 - 27
  • [30] Is weekly administration of paclitaxel less toxic than 3-weekly? A prospective pharmacovigilance study based on patients'and physicians' reports
    Smadja, MC
    Jenabian, A
    Laurent, S
    Louet, ALL
    DRUG SAFETY, 2004, 27 (12) : 960 - 960
12345